-
New bird flu strain detected in Nigeria
Nigeria has reported two new highly pathogenic avian influenza outbreaks; laboratory results show that the newly discovered virus strain (H5N1, clade 2, EMA3) is genetically different from the strains that circulated in Nigeria during earlier outbreaks
-
-
The pandemic potential of H9N2 avian influenza viruses
Researchers show that some currently circulating avian H9N2 viruses can transmit to naïve ferrets placed in direct contact with infected ferrets — but aerosol transmission was not observed, a key factor in potentially pandemic strains
-
-
Indonesia probes bird flu outbreak in Sumatra
Thirteen people in a Sumatra village taken ill with what Indonesian specialists think is a bird flu outbreak; the deadly H5N1 strain of bird flu has killed more than 240 people worldwide since late 2003; Indonesia is the country worst-hit by the virus
-
-
New virus fights other viruses by spreading at their expense
Newly discovered virsu may help fight viral infections by hijacking the replication machinery of the lethal viruses; the new virsus — called Sputnik — is the first member of a new class they call “virophages”
-
-
Bacteria were the real killers in 1918 flu pandemic
Medical and scientific experts now agree that bacteria, not influenza viruses, were the greatest cause of death during the 1918 flu pandemic
-
-
Booster vaccination to help against avian influenza pandemic
Evidence suggests that a booster vaccination against H5N1 avian influenza given years after initial vaccination with a different strain may prove useful in controlling a potential future pandemic
-
-
Calgary researcher wins NIH grant for bacterial vaccine
CDC considers glanders and melioidosis as potential bioterrorism agents; Canadian researcher receives NIH grant to develop a vaccine
-
-
Is the U.S. prepared for a bioterror attack?
Some experts believe a bioterrorist attack or pandemic outbreak could be inevitable. How would the United States fight back against an infectious disease outbreak?
-
-
Corgenix expanding hemorrhagic fever virus product program
Recent outbreaks of the Lassa Hemorrhagic Fever in Africa show urgent need for new products that can be processed in any clinical or field lab
-
-
Good results in tests for BioNeutral's anti-anthrax technology
New Jersey company uses its Ygiene formulation to kill anthrax spores on contact; formulation killed all anthrax spores exposed to the formulation in as little fifteen seconds
-
-
New bird flu vaccine looks promising
Baxter’s cell-based vaccine appears to work better than more traditional egg-based ones; tests show promise at low doses
-
-
India to test anthrax vaccine
India is worried about bioterror attacks by Islamic extremists; it starts testing the potency of U.S.-manufactured vaccine; initially enough doses will be stored to protect military personnel
-
-
Investing in biodefense companies
Billions of dollars are pouring into biodefense vaccines and treatments; do companies engaged in developing such vaccines and treatment offer attractive investment opportunities? The answer is a qualified “Yes” to this specific question — but a more resounding “Yes” when these companies’ other research and development endeavors are taken into consideration
-
-
Florida stocks cyanide antidote
Minute quantities of cyanide in smoke contribute to the death from smoke inhalation of 10,000 civilian and firefighter in the United States each year; Florida emergency services decide that emergency units will now be equipped with cyanide antidote
-
-
Insecticides in pet shampoo may trigger autism
New study shows that children growing up in a household in which pet shampoos containing a class of insecticide called pyrethrins were used, were twice as likely to develop autism spectrum disorder (ASD)
-
